Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
JCO Global Oncology|October 29, 2025
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Gin Gin Gan, et al.
Oncogene|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expressionYichen Sun, Jianfeng Chen, Jing Han Hong, et al.
Journal of Cancer Policy|August 25, 2020
Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer CentreJianbang Chiang, Valerie Shiwen Yang, Shuting Han, et al.
Journal of Hematology & Oncology|February 16, 2021
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 studyHuiqiang Huang, Jun Zhu, Ming Yao, et al.
Journal of Hematology & Oncology|November 19, 2013
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study GroupSeok Jin Kim, Hyun Ae Jung, Shih-Sung Chuang, et al.
Cancers|October 16, 2024
Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell LymphomaChun En Yau, Chen Ee Low, Whee Sze Ong, et al.
Cancer Letters|June 22, 2024
CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphomaYali Wang, Jianfeng Chen, Yan Gao, et al.
Annals of Hematology|January 17, 2024
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumabMin Qing, Tianyuan Zhou, Tatiana Perova, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study GroupSeok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
BMC Medicine|February 7, 2026
Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphomaJason Yongsheng Chan, Elizabeth Chun Yong Lee, Kelila Xin Ye Chai, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
JCO Global Oncology|October 29, 2025
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Gin Gin Gan, et al.
Oncogene|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expressionYichen Sun, Jianfeng Chen, Jing Han Hong, et al.
Journal of Cancer Policy|August 25, 2020
Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer CentreJianbang Chiang, Valerie Shiwen Yang, Shuting Han, et al.
Journal of Hematology & Oncology|February 16, 2021
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 studyHuiqiang Huang, Jun Zhu, Ming Yao, et al.
Journal of Hematology & Oncology|November 19, 2013
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study GroupSeok Jin Kim, Hyun Ae Jung, Shih-Sung Chuang, et al.
Cancers|October 16, 2024
Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell LymphomaChun En Yau, Chen Ee Low, Whee Sze Ong, et al.
Cancer Letters|June 22, 2024
CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphomaYali Wang, Jianfeng Chen, Yan Gao, et al.
Annals of Hematology|January 17, 2024
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumabMin Qing, Tianyuan Zhou, Tatiana Perova, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study GroupSeok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
BMC Medicine|February 7, 2026
Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphomaJason Yongsheng Chan, Elizabeth Chun Yong Lee, Kelila Xin Ye Chai, et al.
Pageof 19